SILVERARC CAPITAL MANAGEMENT, LLC – United Therapeutics Corporation Transaction History
SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:
$2.24M
portfolio value
SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -34.09% | -5.53K shares | -1.58M | $209.38 | 10.69K |
| Q2 2022 | share | Increase | +9.38% | 1.39K shares | 1.16M | $235.64 | 16.22K |
| Q1 2022 | share | Increase | +1.96% | 285 shares | -482K | $179.41 | 14.83K |
| Q4 2021 | share | Decrease | -31.33% | -6.63K shares | -767K | $215.18 | 14.55K |
| Q3 2021 | share | Increase | +38.59% | 5.9K shares | 1.16M | $184.58 | 21.18K |
| Q2 2021 | share | Increase | +185.03% | 9.92K shares | 1.84M | $179.41 | 15.28K |
| Q1 2021 | share | 0.00% | 0 shares | 83K | $167.27 | 5.36K | |
| Q4 2020 | share | Increase | 0.00% | 5.36K shares | 814K | $151.79 | 5.36K |